Wednesday, June 10, 2026

Patent intelligence · AT

AT E190067

PEPTIDE MODIFIZIERT DURCH EINE PHOSPHIN GRUPPE ZUR MARKIERUNG MIT 99MTC UND 186-188RE ODER PARAMAGNETISCHE AGENTIEN

expired A61K 38/ 04 A IA61K 38/ 05 A IA61K 49/ 06 A IA61K 51/ 08 A I
Status expired
Years to expiry 0
Applicant portfolio 2
Patent details — AT E190067
Jurisdiction
AT
Status
expired
Grant date
Mar 15, 2000
Expiration
Mar 10, 2020
CPC classes
A61K 38/ 04 A I, A61K 38/ 05 A I, A61K 49/ 06 A I, A61K 51/ 08 A I
View on Google Patents ↗

Quick answer

AT E190067 (PEPTIDE MODIFIZIERT DURCH EINE PHOSPHIN GRUPPE ZUR MARKIERUNG MIT 99MTC UND 186-188RE ODER PARAMAGNETISCHE AGENTIEN) is held by NYCOMED AMERSHAM SORIN S R L [IT]. Status: expired. Granted Mar 15, 2000. Expires Mar 10, 2020 (0 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
CPC classes
A61K 38/ 04 A I, A61K 38/ 05 A I, A61K 49/ 06 A I, A61K 51/ 08 A I, A61K 51/ 10 A I, A61K/4906

More from NYCOMED AMERSHAM SORIN S R L [IT]

Related pharmaceutical patents in our USPTO index.

  1. EP 1028755

    VERFAHREN ZUR REDUKTION VON OXYGENIERTEN RHENIUM ODER TECHNETIUM VERBINDUNGEN

    NYCOMED AMERSHAM SORIN S R L [IT] · Expires Aug 18, 2020

    expired

Frequently asked questions

What is US patent E190067?

AT E190067 (PEPTIDE MODIFIZIERT DURCH EINE PHOSPHIN GRUPPE ZUR MARKIERUNG MIT 99MTC UND 186-188RE ODER PARAMAGNETISCHE AGENTIEN) is held by NYCOMED AMERSHAM SORIN S R L [IT]. Status: expired. Granted Mar 15, 2000. Expires Mar 10, 2020 (0 years remaining) — relevant for patent-cliff and LOE planning.

Who owns AT E190067?

NYCOMED AMERSHAM SORIN S R L [IT] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 2 pharmaceutical patents for this assignee.

When does AT E190067 expire?

Our index shows an expiration date of Mar 10, 2020 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.